Actual Medicinal Product (AMP) Abacavir 600mg / Lamivudine 300mg tablets (Teva UK Ltd)

This product can't be added to an MCA list.

Stability Information

(Some stability information inherited from generic)

Stability: Lack of data and/or stability concerns exist. MCA use may be acceptable but is likely to be off-label and require mitigation measures. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
Notes: Moisture sensitive medicine. Store in airtight (sealed) MCA. Protect from light. No stability data in MCAs available.
Provenance: This recommendation is based on the products Kivexa 600mg/300mg film-coated tablets (Viiv Healthcare UK Ltd) and Abacavir/Lamivudine 600/300mg film-coated tablets (Aurobindo Pharma – Milpharm Ltd).
Generic: Abacavir + Lamivudine
Formulation: Abacavir 600mg / Lamivudine 300mg tablets